AbbVie Buy Hold or Sell Recommendation

ABBV -- USA Stock  

USD 81.34  1.39  1.74%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding AbbVie is 'Strong Hold'. Macroaxis provides AbbVie buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AbbVie positions. The advice algorithm takes into account all of AbbVie available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from AbbVie buy-and-hold prospective. Check also AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell AbbVieBuy AbbVie
Strong Hold

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon AbbVie has a risk adjusted performance of (0.028183), jensen alpha of (0.19), total risk alpha of (0.47), sortino ratio of 0.0 and treynor ratio of (0.14)
Macroaxis provides buy, hold, or sell suggestion on AbbVie to complement and cross-verify current analyst consensus on AbbVie. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure AbbVie is not overpriced, please confirm all AbbVie fundamentals including its Shares Outstanding, Net Income, Number of Employees, as well as the relationship between Price to Book and Book Value Per Share . Given that AbbVie has Price to Earning of 21.84X, we suggest you validate AbbVie market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

AbbVie Thematic Classifications

Macroaxis Index IdeaMacroaxis Index
Macroaxis power theme of selected equities with solid fundamentals
Giant Impact IdeaGiant Impact
Public companies with mega capitalization

AbbVie Returns Distribution Density

Mean Return0.08Value At Risk2.91
Potential Upside1.93Standard Deviation1.62
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Capital Research Global InvestorsCommon Shares173.6 M16 B
Vanguard Group IncCommon Shares120.6 M11.1 B
Blackrock IncCommon Shares95.8 M8.8 B
State Street CorpCommon Shares64.3 M5.9 B
Capital International InvestorsCommon Shares29.6 M2.7 B
Northern Trust CorpCommon Shares21 M1.9 B
Capital World InvestorsCommon Shares19.3 M1.8 B

AbbVie Greeks

α
Alpha over DOW
=0.19
β
Beta against DOW=0.64
σ
Overall volatility
=1.57
Ir
Information ratio =0.16

AbbVie Volatility Alert

AbbVie exhibits very low volatility with skewness of -1.62 and kurtosis of 4.43. However, we advise investors to further study AbbVie technical indicators to make sure all market info is available and is reliable.
    
 Better Than Average     
    
 Worse Than Average Compare AbbVie to competition

AbbVie Fundamental Vs Peers

FundamentalsAbbViePeer Average
Return On Equity522.70% (15.17)%
Return On Asset11.44% (15.64)%
Profit Margin17.36% (5.50)%
Operating Margin41.75% (10.91)%
Current Valuation148.4B152.14B
Shares Outstanding1.48B1.43B
Shares Owned by Insiders0.08% 6.91%
Shares Owned by Institutions72.17% 18.37%
Number of Shares Shorted22.19M3.24M
Price to Earning21.84X40.69X
Price to Book43.51X14.44X
Price to Sales3.60X17.81X
Revenue32.75B9.85B
Gross Profit25.04B21.75B
EBITDA13.68B1.41B
Net Income5.66B517.71M
Cash and Equivalents8.06B3.89B
Cash per Share5.47X5.17X
Total Debt40.31B7.36B
Current Ratio0.98X3.30X
Book Value Per Share(5.71)X13.64X
Cash Flow from Operations12.4B1.25B
Short Ratio2.83X2.09X
Earnings Per Share3.66X2.30X
Price to Earnings To Growth0.95X1.22X
Number of Employees30K10.67K
Beta0.950.34
Market Capitalization117.92B29.78B
Total Asset53.05B126.86B
Retained Earnings4.38B38.24B
Working Capital5.42B3.58B
Current Asset16.31B36.8B
Current Liabilities10.89B33.34B
   Sale by Laura Schumacher of 25000 shares of AbbVie [view details]

AbbVie Alerts

Trading Alerts and Improvement Suggestions

AbbVie generates negative expected return over the last 30 days
The company currently holds 40.31B in liabilities. AbbVie has Current Ratio of 0.96 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.
About 72.0% of the company shares are held by institutions such as insurance companies

Latest Analysts View

AbbVie Current Analysts Recommendations

Target Median Price87.00
Target Mean Price92.18
Recommendation Mean2.70
Target High Price115.00
Number Of Analyst Opinions17
Target Low Price71.00
Check also AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.
Search macroaxis.com